GLP-1 Is Changing More Than the Scale — Here's What It's Doing to Your Skin

T H E S C I E N C E O F G L P - 1 S K I N 

GLP-1 Is Changing More Than the Scale — Here's What It's Doing to Your Skin 

If you've lost weight on Ozempic, Wegovy, Zepbound, or Mounjaro, you already know the number on the scale isn't the whole story. A lot of our patients tell us the same thing: they're thrilled with their weight loss, but their face and skin don't quite match how they feel. Looser jawline. Hollow cheeks. Skin that feels thinner or less "bouncy" than it used to. 

You're not imagining it, and you're definitely not alone. This is a real, well-documented phenomenon dermatologists are now calling "GLP-1 skin," and the research on it has exploded over the past year. 

What's actually happening under the skin 

A 2026 review in Dermatologic Surgery laid out the mechanics clearly: rapid GLP-1-driven weight loss affects multiple layers of facial structure at once — not just the fat right under your skin, but deeper support fat, and even some bone remodeling. When fat disappears faster than skin can retract, you get the hollowing and sagging patients are noticing. 

At the 2026 SCALE conference, dermatologist Terrence Keaney broke it down into three drivers he watches for in every GLP-1 patient: volume loss, skin laxity, and changes to the skin itself (texture, quality, tone). In a survey of nearly 300 aesthetic providers actively treating GLP-1 patients, over 90% said loss of lean muscle mass was having at least a moderate effect on skin laxity specifically. 

Here's the nuance most articles skip: GLP-1's relationship with skin isn't all bad news. Endogenous GLP-1 actually helps suppress advanced glycation end-products (AGEs) and reactive oxygen species — both of which damage collagen and accelerate skin aging. So GLP-1 therapy is pulling skin in two directions at once: better metabolic and glycemic health on one hand, faster volume and structural loss on the other. Which effect wins out depends heavily on how fast someone loses weight, their age, hydration, and protein intake.

The research on what actually helps 

This isn't just theory — there's now real clinical data on interventions: 

A 12-week, split-face randomized study (Dermatology and Therapy, 2026) tested a topical regimen alongside a single focused ultrasound treatment in GLP-1 patients with mild-to-moderate skin aging. By week 12, the combined approach produced a 44% reduction in skin laxity and a 34% reduction in marionette lines — far outperforming topical treatment alone. 

Separate research on a topical volumizing regimen in rapid-weight-loss patients (pharmacologic, surgical, and behavioral) documented measurable improvements in skin elasticity, not just perceived firmness. 

Multiple 2026 papers — including a Delphi consensus from an international panel of dermatologists — now recommend a combination approach: early collagen biostimulation paired with volume restoration, rather than filler alone. Filler-only correction on GLP-1 patients has been linked to "overfilled" results because it doesn't address the skin quality problem underneath. 

KE Y TAKEAWAY 

The consistent theme across the literature: GLP-1 skin isn't a single problem, so it doesn't have a single fix. 

Why one treatment isn't the answer 

This lines up with what we see clinically. GLP-1 patients rarely walk in with just one concern — most are dealing with some combination of laxity, texture change, pigment shift, redness, and a general "my skin needs help" feeling. Industry data backs this up too: recent provider surveys found the majority of GLP-1 aesthetic patients are requesting treatment for more than one concern at the same visit. 

That's exactly why we built New Visage around a full device platform instead of a single machine. 

How we approach GLP-1 skin at New Visage 

Because we carry the complete Sciton suite, we can build a plan around your specific combination of concerns instead of forcing you into one treatment: 

BBL HEROic — for redness, pigment, and overall skin clarity, especially if glycemic changes have shifted your tone 

Moxi — gentle, non-ablative resurfacing that's ideal for early correction and prevention, or for patients who want minimal downtime 

Halo TriBrid — our most versatile resurfacing platform, combining three wavelengths to address texture, tone, and early laxity signals in one session 

SkinTyte — targeted skin tightening, which directly addresses the laxity component that topical

products alone can't touch 

Erbium (Er:YAG 2940nm) — our resurfacing laser of choice over CO₂, because it gives more controlled, precise results with less thermal spread and less downtime 

ClearSilk — a gentler full-face option for patients with more reactive or sensitive skin 

Most of our GLP-1 patients do best with a layered plan — starting with skin quality and tightening, then reassessing for volume needs once weight has stabilized. That staged approach matches what the current research recommends: address structure and skin quality together, not volume alone. 

If your body is changing, your skincare and treatment plan should evolve with it. Come see us — we'll build a plan around what your skin actually needs, not a one-size-fits-all protocol. 

Ready to talk it through? 

252-808-2639 · newvisagenc.com 

SOU R C ES 

Frank K, Guertler A, Hoffmeister V, et al. GLP-1-Induced Weight Loss and the Face: Anatomical Mechanisms and Rationale for Collagen-Stimulating and Volumizing Aesthetic Treatments. Dermatol Surg. 2026;52(6S):S55-S60. 

Bommareddy K, Fabi S, Muniz M. Aesthetic Considerations for Preventing and Managing GLP-1 Receptor Agonist–Related Facial Aging. J Clin Aesthet Dermatol. 2026;19(7):16-22. 

Keaney T. Practical Strategies for Treating GLP-1-Related Aesthetic Changes. Presented at SCALE 2026, Nashville, TN. 

Moradi A, Kim JH, Kim JM, et al. Clinical Efficacy of a Flavo-Proxylane Topical Regimen Pre- and Post-Ultrasound Procedure for Subjects Undergoing GLP-1 Receptor Agonist Therapy. Dermatol Ther (Heidelb). 2026;16(4):2075-2089. 

Nguyen N, Aguilar A, Afzal N, et al. Topical Volumizing Cream Improves Facial Volume and Skin Health in Adults With Rapid Weight Loss From Pharmacologic, Surgical, or Behavioral Interventions. J Cosmet Dermatol. 2026. 

Nikolis A, Enright KM, Fabi SG, et al. Consensus Statements on Managing Aesthetic Needs in Prescription Medication-Driven Weight Loss Patients: An International, Multidisciplinary Delphi Study. J Cosmet Dermatol. 2025;24(4):e70094. 

Sciton, Inc. "GLP-1 Is Changing More Than the Scale" (McKinsey US Medical Aesthetics Providers Survey, Dec. 2024, n=174; ASDS Consumer Survey, 2026, n=3,500+).